HIGHLIGHTS
- who: Haojia Wang from the Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China have published the research work: Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer by UPLC-MS, network pharmacology, and in vivo experiments, in the Journal: (JOURNAL)
- what: The authors established a xenograft model using human pancreatic cancer cells in nude mice to investigate the anticancer effect of ADI in_vivo.
- how: For screening the following conditions applied the protein structure was obtained by X . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.